ASMA HASHMI: Open Payments
NPI 1598027971 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| Alkermes, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: HETLIOZ, ARISTADA, CAPLYTA, Auvelity, INGREZZA, Jornay PM.
Industry payments across OK — which companies pay providers there.
